NEW YORK, Dec. 8, 2010 /PRNewswire/ — Reportlinker.com
announces that a new market research report is available in its
catalogue:
Prostate Cancer – Spain Drug Forecasts and Treatment Analysis to
2020
http://www.reportlinker.com/p0332354/Prostate-Cancer—Spain-Drug-Forecasts-and-Treatment-Analysis-to-2020.html
Prostate Cancer – Spain Drug Forecasts and Treatment Analysis to
2020
SummaryGlobalData’s pharmaceutical report, “Prostate Cancer –
Spain Drug Forecasts and Treatment Analysis to 2020”. The report is
an essential source of information and analysis on the Spanish
prostate cancer therapeutics market. The report provides
comprehensive information on prostate cancer, highlighting the
treatment guidelines. It identifies and analyzes the key trends
shaping and driving the Spanish prostate cancer therapeutics
market, and analyzes the treatment usage patterns. The report also
provides insights into the competitive landscape and the emerging
players expected to significantly alter the positions of the
existing market leaders. The report provides valuable insights into
the pipeline products within the global prostate cancer sector. It
quantifies the unmet need in the Spanish prostate cancer
therapeutics market, highlighting the opportunity for future
players.
This report is built using data and information sourced from
proprietary databases, primary and secondary research and in-house
analysis by GlobalData’s team of industry experts.
Scope
The scope of the report includes:
– An overview of prostate cancer which includes epidemiology,
etiology, symptoms, diagnosis, pathology and treatment g
‘/>”/>
SOURCE